🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Camlin Fine Sciences Limited CAMLINFINE NSEINFRA

Basic Materials · Specialty Chemicals · India
https://www.camlinfs.com
Company Profile ↓
₹103.13
-52.01% 1Y
Mkt Cap₹1,981.04 Cr
P/E71.62
P/B2.34
52W High₹231.02
52W Low₹96.93
Book Value₹54.19
EPS (TTM)₹1.44

Company Overview

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its products under the Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹1,711.22 Cr (+7.1% YoY); net profit ₹27.63 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +7.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 0.8%, profit CAGR -19.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:0.79%
1 Year:7.10%

Compounded Profit Growth

5 Years:-19.06%
1 Year:-

Stock Price Performance

1 Year:-52.01%
6 Months:-25.00%
3 Months:-22.49%
1 Month:-19.32%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 5% of range
₹96.93 ₹231.02
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)35.79 · Neutral
Price Performance
1M-19.32%
3M-22.49%
6M-25.00%
1Y-52.01%
Valuation vs Sector

P/E of 71.62 is above the sector median of 27.43 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.

CONS

  • Trading at a high P/E of 71.6.
  • Earnings shrank at -19.1% CAGR over 5 years.
  • Trading 55.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
71.62
Industry PE
27.43
Forward P/E
12.65
PEG Ratio
-
Book Value
₹54.19
Price to Book
2.34
P/S
1.41
EV/EBITDA
33.11
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
0.79%
Profit 5Y
-19.06%
Revenue (YoY)
7.10%
Earnings (YoY)
-

Profitability & Returns

ROCE
2.49%
ROE
2.65%
ROA
1.19%
Profit Margin
1.61%
Op Margin
2.76%
Gross Margin
39.04%
EPS (Latest Qtr)
₹4.54
EPS (TTM)
₹1.44

Balance Sheet & Liquidity

Debt/Equity
0.69
Quick Ratio
0.75
Current Ratio
1.27
Debt
₹720.09 Cr
Total Assets
₹2,323.90 Cr
Current Assets
₹1,236.49 Cr
Working Capital
₹262.07 Cr

Ownership

Promoter Holding
44.12%
Chg in Prom Hold
0.01%
FII / Inst Holding
16.03%
Chg in FII Hold
-0.10%

Financial Snapshot

Enterprise Value
₹1,981.04 Cr
Total Revenue (TTM)
₹1,711.22 Cr
EBITDA
₹107.60 Cr
Free Cash Flow
₹24.50 Cr
Operating Cash Flow
₹82.07 Cr
Shares Outstanding
₹19.21 Cr
Gross Margin
39.04%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 CAMLINFINE Camlin Fine Sciences Limited NSEINFRA 103.13 71.62 ₹1,981.04 Cr 0.00% 2.49% 2.65% 0.79% -19.06%
2 ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA 11,408.00 41.12 ₹3.36 L Cr 1.99% 11.84% 10.66% 11.92% 17.26%
3 JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA 1,325.00 14.52 ₹3.24 L Cr 0.54% 18.75% 22.30% 3.61% 75.28%
4 HINDZINC Hindustan Zinc Limited NSEINFRA 601.00 18.36 ₹2.54 L Cr 3.56% 61.97% 61.13% 5.61% 9.58%
5 ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA 2,527.30 56.03 ₹2.42 L Cr 1.00% 24.41% 20.24% 1.10% 1.75%
6 TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA 188.79 21.83 ₹2.36 L Cr 2.11% 11.32% 10.56% -1.59% 7.21%
7 HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA 1,011.00 16.79 ₹2.27 L Cr 0.49% 9.42% 9.80% 7.10% 9.87%
8 GRASIM Grasim Industries Limited NIFTY50NSEINFRA 3,322.00 59.86 ₹2.26 L Cr 0.31% 3.98% 4.80% 14.30% -10.06%
9 SOLARINDS Solar Industries India Limited NSEINFRA 21,445.00 115.68 ₹1.94 L Cr 0.06% 29.51% 26.72% 12.39% 30.36%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 427.00 Cr420.00 Cr406.00 Cr386.00 Cr377.00 Cr381.00 Cr417.00 Cr-431.58 Cr423.55 Cr459.82 Cr457.20 Cr424.81 Cr
Cost of Revenue --------210.80 Cr236.88 Cr246.72 Cr248.02 Cr218.79 Cr
Gross Profit --------220.79 Cr186.67 Cr213.10 Cr209.18 Cr206.02 Cr
Operating Expenses 383.00 Cr381.00 Cr381.00 Cr363.00 Cr345.00 Cr352.00 Cr366.00 Cr-175.88 Cr184.56 Cr195.66 Cr80.49 Cr205.65 Cr
Operating Income 26.00 Cr20.00 Cr6.00 Cr2.00 Cr18.00 Cr14.00 Cr35.00 Cr-44.91 Cr2.11 Cr17.44 Cr128.69 Cr37.12 L
EBITDA 44.00 Cr39.00 Cr25.00 Cr23.00 Cr31.00 Cr29.00 Cr52.00 Cr-63.70 Cr27.56 Cr33.94 Cr7.77 Cr42.71 Cr
Interest Expense 10.00 Cr10.00 Cr20.00 Cr14.00 Cr16.00 Cr23.00 Cr26.00 Cr-9.20 Cr14.90 Cr15.21 Cr18.90 Cr27.16 Cr
Pretax Income 8.00 Cr16.00 Cr-12.00 Cr-10.00 Cr-94.00 Cr-23.00 Cr-142.00 Cr-37.36 Cr-4.26 Cr-9.23 L-27.85 Cr-5.26 Cr
Tax Provision 4.72 Cr4.00 Cr-8.64 Cr-4.70 Cr12.22 Cr-11.04 Cr25.56 Cr-7.69 Cr-1.00 L5.91 Cr4.52 L-6.24 Cr
Net Income 3.00 Cr12.00 Cr-21.00 Cr-14.00 Cr-82.00 Cr-35.00 Cr-116.00 Cr--72.40 L-9.96 Cr-14.38 Cr-36.23 Cr88.20 Cr
Diluted EPS 0.520.83-1.03-0.63-4.11-1.81-5.33--0.04-0.53-0.77-1.914.54

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 558.00 Cr489.00 Cr534.00 Cr721.00 Cr892.00 Cr1,049.00 Cr1,187.00 Cr-1,671.30 Cr1,436.23 Cr1,597.76 Cr1,711.22 Cr
Cost of Revenue --------830.37 Cr792.81 Cr944.39 Cr1,043.19 Cr
Gross Profit --------840.93 Cr643.42 Cr653.37 Cr668.03 Cr
Operating Expenses 474.00 Cr397.00 Cr502.00 Cr705.00 Cr819.00 Cr914.00 Cr1,000.00 Cr-678.94 Cr479.68 Cr487.15 Cr620.84 Cr
Operating Income 68.00 Cr75.00 Cr10.00 Cr-11.00 Cr44.00 Cr102.00 Cr143.00 Cr-161.99 Cr163.74 Cr166.22 Cr47.19 Cr
EBITDA 84.00 Cr92.00 Cr32.00 Cr16.00 Cr73.00 Cr135.00 Cr187.00 Cr-184.02 Cr204.82 Cr212.29 Cr107.60 Cr
Interest Expense 24.00 Cr24.00 Cr31.00 Cr32.00 Cr41.00 Cr48.00 Cr42.00 Cr-41.13 Cr67.62 Cr74.05 Cr65.62 Cr
Pretax Income 53.00 Cr50.00 Cr-6.00 Cr-31.00 Cr17.00 Cr58.00 Cr105.00 Cr-80.38 Cr58.59 Cr64.58 Cr-31.99 Cr
Tax Provision -2.12 Cr14.00 Cr1.56 Cr6.82 Cr13.94 Cr28.42 Cr39.90 Cr-40.57 Cr5.63 Cr-51.23 L-45.51 L
Net Income 55.00 Cr36.00 Cr-4.00 Cr-24.00 Cr3.00 Cr30.00 Cr65.00 Cr-52.11 Cr-92.75 Cr-139.05 Cr27.63 Cr
Diluted EPS 5.113.30-0.96-2.180.042.233.56-3.33-5.49-8.031.44

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 426.00 Cr479.00 Cr669.00 Cr1,016.00 Cr1,087.00 Cr1,232.00 Cr1,475.00 Cr-2,060.10 Cr1,951.72 Cr2,023.79 Cr2,323.90 Cr
Current Assets --------1,087.82 Cr1,000.67 Cr1,183.39 Cr1,236.49 Cr
Cash & Equivalents --------93.74 Cr80.25 Cr104.07 Cr108.56 Cr
Inventory --------568.14 Cr512.70 Cr526.86 Cr503.74 Cr
Receivables --------304.59 Cr285.15 Cr328.22 Cr373.02 Cr
Total Liabilities --------1,236.01 Cr1,094.77 Cr1,149.01 Cr1,323.10 Cr
Current Liabilities --------792.99 Cr732.27 Cr846.21 Cr974.42 Cr
Long Term Debt --------408.10 Cr332.72 Cr268.30 Cr302.61 Cr
Total Debt 160.00 Cr180.00 Cr331.00 Cr373.00 Cr461.00 Cr539.00 Cr550.00 Cr-800.54 Cr683.03 Cr651.80 Cr720.09 Cr
Total Equity 135.00 Cr177.00 Cr212.00 Cr371.00 Cr371.00 Cr403.00 Cr644.00 Cr-819.37 Cr864.75 Cr901.67 Cr1,040.88 Cr
Shares Outstanding --------16.08 Cr17.14 Cr18.79 Cr19.21 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 46.00 Cr72.00 Cr-9.00 Cr-15.00 Cr-9.00 Cr86.00 Cr117.00 Cr-50.90 Cr138.98 Cr23.00 Cr82.07 Cr
Investing Cash Flow -26.00 Cr-66.00 Cr-70.00 Cr-149.00 Cr-2.00 Cr-90.00 Cr-133.00 Cr--124.63 Cr-66.50 Cr-75.35 Cr-52.95 Cr
Financing Cash Flow -15.00 Cr-7.00 Cr91.00 Cr182.00 Cr26.00 Cr3.00 Cr39.00 Cr-59.66 Cr-85.97 Cr76.17 Cr-24.63 Cr
Capital Expenditure -27.00 Cr-67.00 Cr-30.00 Cr-19.00 Cr-69.00 Cr-134.00 Cr-83.00 Cr--144.31 Cr-60.58 Cr-42.45 Cr-57.57 Cr
Free Cash Flow 19.00 Cr5.00 Cr-39.00 Cr-34.00 Cr-78.00 Cr-48.00 Cr34.00 Cr--93.41 Cr78.41 Cr-19.45 Cr24.50 Cr
Net Change in Cash 4.00 Cr-1.00 Cr13.00 Cr18.00 Cr15.00 Cr-1.00 Cr23.00 Cr--14.07 Cr-13.49 Cr23.82 Cr4.48 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------50.3%44.8%40.9%39.0%
Operating Margin % 12.2%15.3%1.9%-1.5%4.9%9.7%12.0%-9.7%11.4%10.4%2.8%
Net Margin % 9.9%7.4%-0.7%-3.3%0.3%2.9%5.5%-3.1%-6.5%-8.7%1.6%
ROE % 40.7%20.3%-1.9%-6.5%0.8%7.4%10.1%-6.4%-10.7%-15.4%2.7%
ROCE % --------12.8%13.4%14.1%3.5%

Shareholding Pattern

Insiders
44.12%
Institutions
16.03%
Public Float
28.68%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CAMLINFINE

Google News Wed, 04 Feb 2026

Camlin Fine Sciences Limited's (NSE:CAMLINFINE) market cap up ₹5.7b last week, benefiting both retail investors who own 35% as well as insiders - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNSHlHUjhQNFVyTDgzRXJZMk55cEJYdThXQ0NHZXMxVEtid1ItU1pDSnExUGxmNWtpX3BpcHJjV2tPWGtscUVHZFZNbW1VYlM2QnlkcW1ORzhYVHI3WXJtdHpTOVRyd3BFdDVrQnV6ME1vZXNQU2g5eUhXUnJleXcwRW1wZE1IenJVS3d4Ym…

Google News hu, 02 Jul 2026

Camlin Fine Sciences (CAMLINFINE.NS) Gains 3.4%, Breaks Past Key Support Zone - Low Beta Factor - vinanet.vn

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQZHdPZVQ5WWx5Wk5Td0RDVkdySzRDb3NWMWo0M0paUnVUb2xfa21wdTd1TGpBNTV2LTN5cHhoRXVMZzBVSFc1TVhub1plMDF6bVBvc2VyVWhuTloyUzFPUURVNmxZWnZENFJGREhHUmt5Qy05LU4yN3BvakFOV191OUk3NmpaUkFWanFheT…

Google News Sun, 30 Aug 2026

Camlin Fine Sciences clears AMF offer for Vinpai at EUR 3.60 - scanx.trade

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMlFNRVF0SFZaQW5nWXBNQnVUTVhiMVNnWjhnR0tSdVV0VjFNSVJLaUpJM2Qyb1Y1WnFlVHo5b1VOZ3JqQ0R0Q0ZFTmIxSXdqUXlmSHpvRERNeEtrX2FVMjB3bFhHZm1EQXBDaHNtcEFhY2ZBcDNRVmtqcG9zdmh1WVFvUUtfUlV3ZGtOMU…

Google News ue, 09 Dec 2025

It's Down 26% But Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Riskier Than It Looks - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOUDVwMjdwRzJqYUR2SXhOaGFHZlAxMlQwMFp1LUpVbE43ZUNVTEk4V1B6WjFnTmNXOHdVVDJFcUlBM18zeWtJODExVnhTRWR5RV83QW1wZzdqVURWSHVzZzdrQmhaeUpIXy1wampQeC04VlJ6ajBtdDVpb3FCa1Y4RzlzZ3NTTkE1UjAtan…

Google News Sat, 20 Jun 2026

AMF clears Camlin Fine Sciences’ mandatory takeover offer for Vinpai - Indian Chemical News

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQeVhOS3ZNXzdTR1NEZ056VjB6VmdTdV9jeDlJYkZ4cWxZTlBBU0otSDVTY05RU09jRnA1YUwxM3RZTVZQYUUxTURPTUVSQUtIZ1NBMzlBUTQ3cGdCdWg0WktDazI2bHNraVVQaTVSckEtcWZvb1ZjODNoaEttS05DaGdmaXZmWDhRTHZoQW…

Google News hu, 04 Jun 2026

Camlin Fine Sciences Share Analyst Review 2026: Price Target and Outlook - Univest

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTFBuZ2FCcC1yTDQ3cFFBR19NTzNfejFld0gxNC1YQlZPU2dqRjdLQ2E5RXRCZURwZzNWS0FCRk1VZU1IeHpKVmgtc1NaTkJtS1ljZ0VqUFp3UXRscmNoN0F0MkRwaWZkblY4U0NRdFlOS0hrTVh0eWNVLURwVQ?oc=5" target="_blank">C…

CAMLINFINE — Frequently Asked Questions

What is the current share price of Camlin Fine Sciences Limited (CAMLINFINE)?

As of 2026-09-08 04:53 IST, Camlin Fine Sciences Limited (CAMLINFINE) trades at ₹103.13 on NSE. Its 52-week range is ₹96.93 to ₹231.02.

What is the market capitalisation of CAMLINFINE?

Camlin Fine Sciences Limited (CAMLINFINE) has a market capitalisation of ₹1,981.04 Cr on NSE.

What is the P/E ratio of CAMLINFINE?

CAMLINFINE trades at a trailing price-to-earnings (P/E) ratio of 71.62. The industry average P/E is 27.43. Its price-to-book (P/B) ratio is 2.34.

What is the return on equity (ROE) of CAMLINFINE?

CAMLINFINE has a return on equity (ROE) of 2.65%. Its return on capital employed (ROCE) is 2.49%.

Is CAMLINFINE a good stock to buy?

This page provides a data-driven analysis of Camlin Fine Sciences Limited (CAMLINFINE), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space